Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia

American Journal of Medicine

Volumn 103, Issue 1, 1997, Pages 25-32

  Nasser, Rana M ^a   Melgar, Gerardo R ^a   Longworth, David L ^a   Gordon, Steven M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCARDITIS; FUNGEMIA; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HOSPITAL INFECTION; HUMAN; INCIDENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0030795633     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)90050-4     Document Type: Article

References (26)

1. Graves E. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1992. National Center for Health Statistics. Vital Health Stat. 1994;13(118):117.
2. Banerjee S, Emori T, Culver D, et al. Secular trends in nosocomial primary bloodstream infections in the United States. Am J Med. 1991;91(suppl 3 B):865-895.
3. Pittet D, Wenzel R. Nosocomial bloodstream infections: Secular trends in rates, mortality, and contribution to hospital deaths. Arch Intern Med. 1995;155:1177-1183.
4. Ivert T, Dismukes W, Cobb C, Blackstone E, Kirklin J, Bergdahl L. Prosthetic valve endocarditis. Circulation. 1984;69:223-232.
5. Arnett E, Roberts W. Prosthetic valve endocarditis. Clinicopathologic analysis of 22 necropsy patients with comparison of observation in 74 necropsy patients with active infective endocarditis involving natural left-sided valves. Am J Cardiol. 1979;38:281-292.
6. Gordon S, Keys T. Bloodstream infections in patients with prosthetic cardiac valves. Sem Thoracic Cardiovasc Surg. 1995;7:2-6.
7. Scheld W, Sande M. Endocarditis and Intravascular Infections. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Diseases, Vol. 1. New York: Churchill Livingstone; 1994:740-783.
8. Moyer D, Edwards J. Fungal Endocarditis. In: Kaye D, ed. Infective Endocarditis, 2nd ed. New York: Raven Press; 1992:299-312.
9. Rubinstein E, Noriega E, Simberkoff M, Rahal J. Tissue penetration of amphotericin B in candidal endocarditis. Chest. 1974;66:376-377.
10. Chaudhuri M. Fungal endocarditis after valve replacements. J Thorac Cardiovasc Surg. 1970;60:207-214.
11. Seelig M, Speth C, Kozinn P, Taschdjian C, Toni E, Goldberg P. Patterns of Candida endocarditis following cardiac surgery: Importance of early diagnosis and therapy (an analysis of 91 cases). Prog Cardiovasc Dis. 1974;17: 125-160.
12. Norenberg R, Sethi G, Scott S, Takaro T. Opportunistic endocarditis following open-heart surgery. Ann Thorac Surg. 1975;19:592-604.
13. Johnston PG, Lee J, Domanski M, et al. Late recurrent candida endocarditis. Chest. 1991;99:1531-1533.
14. Gilbert H, Peters E, Lang S, Hartman B. Successful treatment of fungal prosthetic valve endocarditis: Case report and review. Clin Infect Dis. 1996; 22:348-354.
15. Nguyen M, Nguyen M, Yu V, McMahon D, Keys T, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis. 1996;22:262-267.
16. Fang G, Keys T, Gentry L, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. Ann Intern Med. 1993;119:560-567.
17. Sande M, Johnson W, Hook E, Kaye D. Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med. 1972;286:1067-1070.
18. Von Reyn C, Levy B, Arbeit R, Friedland G, Crumpacker C. Infective endocarditis: An analysis based on strict case definitions. Ann Intern Med. 1981; 91:505-518.
19. Durack D, Lukes A, Bright D. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994; 96:200-209.
20. Wilson J, Jaumin P, Danielson G, Giuliani E, Washington J, Geraci J. Prosthetic valve endocarditis. Ann Intern Med. 1975;82:751-756.
21. Bayer A, Witt M, Kim E, Ghannoum M. Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob Agents Chemother. 1996; 40:494-496.
22. Seelig M, Kozinn P, Goldberg P, Berger A. Fungal endocarditis: patients at risk and their treatment. Postgraduate Med J. 1979;55:632-641.
23. Muehrcke D. Fungal prosthetic valve endocarditis. Sem Thorac Cardiovasc Surg. 1995;7:20-24.
24. Czwerwiek F, Bilsker M, Kamerman M, Bisno A. Long term survival after fluconazole therapy of candidal prosthetic valve endocarditis. Am J Med. 1993;94:545-546.
25. Zahid M, Koltz S, Hinthorn D. Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. Chest. 1994;105:1597-1598.
26. Isalska B, Stanbridge T. Fluconazole in the treatment of candidal prosthetic valve endocarditis. Bri Med J. 1988;297:178-179.